The Clinical Study of Acute Pancreatitis Treated by TongFuSan

Status Recruiting

Clinical Trial Summary

The purpose of this study is to determine whether TongFuSan is effective in the treatment of acute pancreatitis with gastrointestinal dysfunction.

Clinical Trial Description

- Patient who is diagnosed with acute pancreatitis(AP) should be included.

- Patients will be divided into two groups as random number table: control group(A) and experimental group(B).

- Group A will be given Mosapride po,and group B will be given TongFusan except for basic treatments of AP.

- Same investigator will write the case report form.

- Investigator will collect the patients' blood in three points: on admission, the third day and the seventh day.

- Otherwise, we need write down patients' clinical manifestation,Traditional Chinese Medicine differentiation, the result of clinical tests.

- When the patient discharge, we will write down the treatment measures, therapeutic effect, length of stay and the costs. ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02204189
Study type	Interventional
Source	Beijing Friendship Hospital
Contact	Hong You, PHD
Phone	010-63139197
Status	Recruiting
Phase	Phase 1/Phase 2
Start date	March 2014
Completion date	February 2017

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05410795` - Establishment and Verification of Pancreatic Volume Formula Based on Imaging
Recruiting	`NCT04195347` - Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase	Phase 1/Phase 2
Completed	`NCT04735055` - Artificial Intelligence Prediction for the Severity of Acute Pancreatitis
Completed	`NCT02928718` - The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations
Terminated	`NCT02885441` - Treatment of Acute Pancreatitis With Ketorolac	Phase 4
Completed	`NCT02563080` - Pancreatic Exocrine Insufficiency in Acute Pancreatitis
Recruiting	`NCT01626911` - Continuous Regional Arterial Infusion of Low Molecular Weight Heparin in Patients With Severe Acute Pancreatitis	N/A
Completed	`NCT01507766` - The Correlations Between Early Enteral Nutrition and Intra-abdominal Pressure in Severe Acute Pancreatitis	Phase 4
Completed	`NCT04901949` - The Course of Acute Pancreatitis in Patients With Different BMI Groups
Recruiting	`NCT04814693` - Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis	N/A
Completed	`NCT02743364` - Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis	Phase 2
Recruiting	`NCT05281458` - Early Versus Standard Endoscopic Interventions for Peripancreatic Fluid Collections	N/A
Not yet recruiting	`NCT04990336` - Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis	N/A
Not yet recruiting	`NCT03259880` - Searching the Best Prognostic Factor in Out Come Evaluation in Patients With Acute Pancreatitis Admitted at Assiut University Hospitals	N/A
Completed	`NCT02543658` - Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension	Phase 2
Recruiting	`NCT06023771` - Invasive Intervention of Local Complications of Acute Pancreatitis
Not yet recruiting	`NCT05501314` - Remote Home Monitoring Acute Pancreatitis	N/A
Completed	`NCT02897206` - Imipenem Prophylaxis in Patients With Acute Pancreatitis	Phase 4
Recruiting	`NCT03634787` - Heat Shock Proteins: a Pathogenic Driver and Potential Therapeutic Target in Acute Pancreatitis
Active, not recruiting	`NCT04989166` - Effect of Nano-curcumin Supplementation in Acute Pancreatitis	N/A